Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis—a pharmacokinetic study

Background. Daptomycin is a new intravenous cyclic lipopeptide antibiotic, licensed for the treatment of complicated skin and soft tissue infections caused by Gram-positive organisms including both susceptible and resistant strains of Staphylococcus aureus and for the treatment of various infections...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nephrology, dialysis, transplantation dialysis, transplantation, 2010-05, Vol.25 (5), p.1537-1541
Hauptverfasser:	Kielstein, Jan T., Eugbers, Catrin, Bode-Boeger, Stefanie M., Martens-Lobenhoffer, Jens, Haller, Hermann, Joukhadar, Christian, Traunmüller, Friederike, Knitsch, Wolfgang, Hafer, Carsten, Burkhardt, Olaf
Format:	Artikel
Sprache:	eng
Schlagworte:	acute kidney injury Acute Kidney Injury - metabolism Adult Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Anti-Bacterial Agents - pharmacokinetics Biological and medical sciences daptomycin Daptomycin - pharmacokinetics Emergency and intensive care: renal failure. Dialysis management extended dialysis Female Humans Intensive care medicine Intensive Care Units Male Medical sciences Middle Aged pharmacokinetics Prospective Studies Renal Dialysis Staphylococcus aureus Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the urinary system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!